We went on to examine whether treatment with the SERCA2 agonist ISTA would promote bone mechano-responsiveness in genetically spontaneous T2D mice (KK-Ay mice) in response to a cyclic compressive loading of 1200 cycles/day for 2 weeks (Fig. 6a). Here, ATP2A2 is linked to type 2 diabetes mellitus.